(Q46643922)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

S L Lui

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

R Tsang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

F Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

K W Chan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

S Tam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

T M Chan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

305-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

Systemic lupus erythematosus

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Update on the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Sirolimus: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Imatinib ameliorates renal disease and survival in murine lupus autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203307088289

21 January 2018

Identifiers

DOI

10.1177/0961203307088289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18413412%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference